26.12.2023 14:52:58
|
Immunome To Purchase Antibody Assets From Atreca
(RTTNews) - Immunome, Inc. (IMNM) Tuesday announced a definitive asset purchase agreement with Atreca, Inc. (BCEL) to acquire a collection of antibody-related assets and materials.
The biotechnology company targetting cancer therapies said it would pay Atreca a $5.5 million upfront payment and up to $7.0 million in clinical development milestones.
Immunome CEO Clay Siegall said, "These antibody-related assets will expand our toolbox, complementing our existing programs as we advance our mission of developing innovative treatments for cancer patients."
![](https://images.finanzen.at/images/unsortiert/wertpapierdepot-absichern-aktienchart-boerse-750493204-260.jpg)
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Atreca Inc Registered Shs -A-mehr Nachrichten
Keine Nachrichten verfügbar. |
Analysen zu Atreca Inc Registered Shs -A-mehr Analysen
Aktien in diesem Artikel
Atreca Inc Registered Shs -A- | 0,16 | -33,05% |
|
Immunome Inc Registered Shs | 10,40 | -0,29% |
|